Wandercraft announces launch of US commercial operations with the start of Atalante X research at Kessler Foundation
- Company opens US corporate headquarters in New York, led by CEO Matthieu Masselin
- First Atalante X exoskeleton for clinical research already delivered to Kessler Foundation and staff training is complete
- Kessler Foundation research team will analyze Atalante X to investigate the possible benefits for neurologically impaired patients, including those recovering from stroke, spinal cord injuries, and motor neuron disease
NEW YORK CITY, New York, 12 October 2023 — Wandercraft, the developer of the world’s first self-stabilizing walking exoskeleton, designed to enable people with walking impairments to stand and walk again, announced today the official launch of commercial operations in the United States with the start of Atalante X research at Kessler Foundation, a global leader in rehabilitation research.
Wandercraft’s US headquarters, based in New York and led by CEO Matthieu Masselin, have opened as the Company looks to ramp up operations in the US following FDA clearance of the Atalante exoskeleton for use in stroke rehabilitation in December 2022.
A large number of individuals with disabilities in the US may benefit from using the Atalante X exoskeleton. According to the Centers for Disease Control and Prevention, more than 795,000 people in the United States have a stroke each year and this is a leading cause of serious long-term disability. In addition, approximately 302,000 people living in the United States have experienced a traumatic spinal cord injury according to the US National Spinal Cord Injury Statistical Center. Finally, approximately one million people in the US are living with multiple sclerosis according to the National Multiple Sclerosis Society.
Wandercraft’s Atalante X received a CE-mark* in 2019 and has been used to treat over 650 patients in almost 5,500 sessions for various medical conditions across multiple European rehabilitation hospitals. Its unique self-balancing feature enables patients to move in multiple directions hands-free, without an assistive device, and includes a dynamic balance mode unavailable elsewhere in the exoskeleton market. The Active Balance mode allows the exoskeleton to follow the movement of the patient thanks to a motion sensor placed on their back, which enables more freedom in the rehabilitation program, including gamification of the sessions to keep the patients engaged and work on core strength and balance as well as gait.
“Building our presence in the world’s largest healthcare market and announcing this partnership with Kessler Foundation are two significant milestones in our goal to revolutionize standards of care and providing a pathway to recovery for patients with severe mobility issues,” said Matthieu Masselin, CEO of Wandercraft. “Wandercraft has strong clinical and engineering expertise, and we are always looking to partner with respected institutions that work with state-of-the-art technologies to improve clinical solutions for patients and clinicians.”
The first Atalante exoskeleton for research use has been delivered to Kessler Foundation and staff training has been completed. Kessler’s research team, led by Gail Forrest, PhD, Karen J. Nolan, PhD, and Ghaith Androwis PhD, is investigating the impacts of this innovative robotic technology on biomechanics and functional mobility.
“With more than two decades of experience researching wearable exoskeletons, our team has the depth and scope of expertise needed to study innovations such as Atalante,” said Gail Forrest, PhD, director of the Tim and Caroline Reynolds Center for Spinal Stimulation and associate director of the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation. “Most importantly, we are examining the inherent capabilities of this powered exoskeleton, and how it interfaces with the user’s neuromuscular system to help maintain balance and facilitate walking,” Dr. Forrest explained.
“After testing in healthy volunteers, we will conduct pilot studies in individuals with a variety of mobility impairments, including those caused by stroke, spinal cord injury, and multiple sclerosis,” added Karen J. Nolan, PhD, associate director of the Center for Mobility and Rehabilitation Engineering Research and director of the Center’s Acquired Brain Injury Mobility Laboratory. “By working with the Wandercraft team, we anticipate gaining insight into ways to improve gait rehabilitation through advanced robotic-assisted walking.”
– Ends –
*The Conformité Européene (CE) Mark is defined as the European Union’s (EU) mandatory conformity marking for regulating the goods sold within the European Economic Area (EEA) since 1985. The CE marking represents a manufacturer’s declaration that products comply with the EU’s New Approach Directives.
Wandercraft is a global manufacturer developing and commercializing advanced robotic solutions to enable people with walking impairments to stand up and walk again. The Company has used its engineering expertise to design Atalante X, the world’s first self-stabilizing walking exoskeleton which emulates human walking and provides hands-free multi-directional locomotion. Atalante X is already used by many hospitals and healthcare facilities in Europe and the USA. Several different walking programs are designed to support rehabilitation and greater independence.
For more information, please visit www.wandercraft.eu.
About Kessler Foundation
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research. Our scientists seek to improve cognition, mobility, and long-term outcomes, including employment, for adults and children with neurological and developmental disabilities of the brain and spinal cord including traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, and autism. Kessler Foundation also leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.
VP of commercial operations Americas
+1 (813) 435-0772
Consilium Strategic Communications (for Wandercraft)
Mary-Jane Elliott, Ashley Tapp, Andrew Stern
+44 (0)20 3709 5700
+1 (201) 803-0572
Autonomous aerial vehicles have made headlines since the start of the Ukraine war, with commercial drones changing tactics almost overnight. Given this transformation, policymakers are calling for a renewed focus on autonomy on the ground.
The U.S. Department of Defense is at an important juncture as it thinks creatively and ambitiously on how to leverage this critical new technology at scale for strategic advantage.
The last decade has seen significant technological progress on the ground. An AI-driven revolution is currently underway on American roadways, with important implications for both our economic competitiveness and our national security. After many years and billions of dollars of private sector R&D, autonomous vehicles have arrived.
While autonomous technology will soon begin to fundamentally change the way goods and people move, its impact may soon reach far beyond American roadways. AVs will change the strategy for modern ground warfare while saving lives and keeping our service members out of many dangerous situations.
For years, the U.S. Army has experimented with autonomous ground operations, in which a human-driven leader vehicle would chart a path for one or more autonomous follower vehicles. While the “Leader-Follower” approach frees up manpower and reduces potential human casualties, it also makes leader trucks high-value targets; disabling a single lead vehicle could potentially put an entire convoy at risk.
While the technology developed for “Leader-Follower” was a major innovation, in the past five years American commercial autonomy developers have leapfrogged the many DoD-funded efforts. Passengers can now hail driverless taxis in multiple cities and developers are planning to deploy the first driverless trucks next year — no “leader” vehicle is required.
While these vehicles are not yet as resourceful as human drivers, they are programmed to come to a safe stop, pull over, return to base, or even call for a human to offer remote assistance.
Encouraged by this progress, the Defense Innovation Unit, in partnership with the Army, piloted a program in 2022 to leverage commercial autonomous solutions to make the Robot Combat Vehicle fully autonomous. Through this defense acquisition approach, DoD reaps the benefits of continuous software improvements being learned on U.S. roads every day, while de-risking its technological investments and ensuring solutions are being developed and integrated at the speed of relevance.
The Army continues to think through the best use cases that leverage AVs for high-risk missions such as re-supply, reconnaissance support, casualty evacuation, route clearance, and explosive ordnance disposal. Using human-robot teams offers a solution to an enduring challenge for ground forces — building mass to leverage as a force multiplier. Allowing each soldier to control a small fleet of ground and air systems has the potential to address this challenge, exponentially increasing the capability and flexibility of deployed forces.
Human-robot teams will offer additional capabilities beyond what humans can do alone. Low-cost, attritable autonomous systems can overwhelm adversarial forces by saturating an operational area to force an adversary to move, be detected, or be targeted. They may be able to employ deception to confuse the adversary’s operational picture by making it difficult to differentiate real targets from decoys.
Ground vehicles could also be outfitted with ISR assets and short-range air and missile defense systems and driven autonomously to forward deployed positions to provide better situational awareness, planning, lethality, decision support, and more dispersed and enhanced protection for soldiers in theater.
Re-imaging Army acquisition
However, to fully harness this burgeoning technology and take advantage of the tremendous progress in the commercial sector, the Army should re-imagine its acquisition strategies and be open to new concepts of operations. While Ukraine has understandably caused the Army to double down on its existing focus on resiliency and lethality to better prepare for a high-intensity conflict, it should also be thinking critically about how autonomous systems can focus on injecting redundancy, flexibility, and adaptability into force structure through autonomous systems.
A common myth in defense circles is that commercial industry can only function with fixed infrastructure, well-mapped roads, and structured environments. The reality is that American highways are incredibly unpredictable environments, on par with what Army vehicles must contend with.
The millions of autonomous miles of public road driving these companies have completed gives them a significant advantage as they adapt their mature systems to make meaningful progress in complex environments, off-road, and without a human driver in the vehicle. Companies that are operating commercially will deliver an autonomous solution to the military faster; they have moved beyond science experiments and lab demonstrations to developing and delivering a product.
When it comes to adopting ground autonomy at scale, the U.S. military needs to think ambitiously about how to leverage the advances of the commercial sector for a meaningful strategic advantage for the troops.
Don Burnette is the founder & CEO of Kodiak Robotics, a Mountain View, California-based supplier of autonomous vehicle technology. Lt. Gen. Joe Anderson (ret.) is a former Deputy Chief of Staff of the Army.
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) — The “Commercial Robots Market By Type (Field Robots, Medical robots, Autonomous Guided Robotics, Drones, Others), By Application (Medical and Healthcare, Defense and Security, Agriculture and Forestry, Marine, Other): Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
The global commercial robots market, valued at $15.2 billion in 2021, is anticipated to achieve remarkable growth, projecting an estimated value of $85.2 billion by 2031, exhibiting a robust Compound Annual Growth Rate (CAGR) of 20.0% from 2022 to 2031.
Commercial robots, transformative devices designed to mimic, assist, or even replace human tasks, are witnessing surging demand due to their superior capabilities over conventional methods. Notably, drones are making inroads into various sectors, including commercial applications.
The ever-growing demand for innovative medical treatments has significantly expanded the commercial robot devices market. Incorporating machine learning and artificial intelligence into healthcare has broadened the scope of robotic surgery and medical robotics. Companies are leveraging research and development efforts to create automated solutions for the healthcare industry, resulting in a surge in demand for commercial robots, especially in automated surgical procedures.
However, the market faces challenges in terms of high installation and maintenance costs for commercial robotic systems. The expenses are primarily associated with software programming, setup, maintenance, and additional parts, including the constant power supply required for optimal operation. Despite these challenges, the market’s expansion is being driven by the increasing adoption of commercial robots, particularly autonomous guided drones, across diverse sectors such as manufacturing, packaging, mining, and medical applications.
Numerous startups and industry giants are heavily investing in commercial robotic technology to swiftly gain a competitive edge. Public and private collaborations are further shaping the market landscape. For instance, in August 2022, the Drone Federation of India and the Indian Army Design Bureau signed a memorandum of understanding (MoU) to foster the development of drone technology and promote localization in the drone industry.
- Increasing Investment in Commercial Robots
- Growth in Medical Robotics and Surgical Solutions
- Proliferation of Autonomous Guided Drones
- High Installation and Maintenance Costs
- Technological Advancements in Robotic Applications
- Collaborations and Partnerships for Innovation
The comprehensive market report offers stakeholders several benefits, including:
- Quantitative analysis of market segments, trends, and dynamics from 2021 to 2031.
- Insights into key drivers, restraints, and opportunities influencing the market.
- Porter’s five forces analysis to guide profit-oriented decision-making.
- In-depth segmentation analysis to identify prevailing market opportunities.
- Revenue contribution mapping of major countries within each region.
- Benchmarking and understanding the market player landscape.
Key Market Segments:
- Medical and Healthcare
- Defense and Security
- Agriculture and Forestry
- Field Robots
- Medical Robots
- Autonomous Guided Robotics
- North America: U.S., Canada, Mexico
- Europe: Germany, UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
- LAMEA: Brazil, Saudi Arabia, UAE, South Africa, Rest of LAMEA
Key Market Players:
Leading players in the commercial robots market include Northrop Grumman Corp., Kuka AG, iRobot Corporation, yaskawa electric corporation, Omron Adept Technologies Inc., Honda Motor Company Limited, 3D Robotics Inc., Alphabet Inc., Accuray Inc., and AeroVironment Inc.
For more information about this report visit https://www.researchandmarkets.com/r/i67b2y
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.